US2007196489A1PendingUtilityA1
Taste masked pharmaceutical particles
Est. expiryJun 30, 2020(expired)· nominal 20-yr term from priority
A61K 9/2081A61K 9/5042A61K 9/16A61K 9/0056
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Taste masked particles and chewable tablets made therefrom are disclosed. The taste masked particles comprise a core containing an active ingredient and a polymeric coating covering said core, said coating comprising a mixture of a) an enteric polymer; and b) an insoluble film forming polymer, the surface of said particle being free of active ingredient. The chewable tablets provide immediate release of the active ingredient.
Claims
exact text as granted — not AI-modified1 . A taste masked particle comprising a core containing an active ingredient and a continuous polymeric coating covering said core, said coating comprising a mixture of a) an enteric polymer selected from the group consisting of hydroxypropyl methylcellulose phthalate, hydroxypropyl methylcellulose acetate succinate, cellulose acetate phthalate, polyvinylacetate phthalate, and mixtures thereof; and b) a water insoluble film forming polymer selected from the group consisting of cellulose acetate, ethylcellulose, and mixtures thereof, wherein the active ingredient is a nonsteroidal anti-inflammatory drug and wherein the weight ratio of enteric polymer to water insoluble film forming polymer in the coating is in the range of about 55:45 to about 80:20.
2 . The particle of claim 1 , wherein the surface of said particle is substantially free of active ingredient.
3 . The particle of claim 1 , wherein the coating is substantially free of plasticizer.
4 . The particle of claim 1 , wherein the active ingredient is a nonsteroidal anti-inflammatory drug selected from the group consisting of ibuprofen, ketoprofen, flurbiprofen, naproxen, diclofenac, rofecoxib, celecoxib, aspirin, pharmaceutically acceptable salts and metabolites thereof, and mixtures thereof.
5 . (canceled)
6 . (canceled)
7 . The particle of claim 1 further comprising a non-enteric, water soluble polymer.
8 . The particle of claim 1 further comprising a surfactant.
9 . (canceled)
10 . (canceled)
11 . A chewable tablet comprising taste masked particles, each particle comprising a core containing an active ingredient and a continuous polymeric coating covering said core, said coating comprising a mixture of a) an enteric polymer selected from the group consisting of hydroxypropyl methylcellulose phthalate, hydroxypropyl methylcellulose acetate succinate, cellulose acetate phthalate, polyvinylacetate phthalate, and mixtures thereof; and b) a water insoluble film forming polymer selected from the group consisting of cellulose acetate, ethylcellulose, and mixtures thereof, wherein the active ingredient is a nonsteroidal anti-inflammatory drug and wherein the weight ratio of enteric polymer to water insoluble film forming polymer in the coating is in the range of about 55:45 to about 80:20.
12 . The chewable tablet of claim 11 , wherein the surfaces of the particles are substantially free of active ingredient.
13 . The chewable tablet of claim 11 , wherein the coating is substantially free of plasticizer.
14 . The chewable tablet of claim 11 , wherein the active ingredient is a nonsteroidal anti-inflammatory drug selected from the group consisting of ibuprofen, ketoprofen, flurbiprofen, naproxen, diclofenac, rofecoxib, celecoxib, aspirin, pharmaceutically acceptable salts and metabolites thereof, and mixtures thereof.
15 . (canceled)
16 . (canceled)
17 . The chewable tablet of claim 11 , wherein said coating further comprises an ingredient selected from the group consisting of non-enteric, water soluble polymers and surfactants.
18 . (canceled)
19 . A method of taste masking particles comprising an active ingredient, which comprises applying a continuous polymeric coating over said particles, said coating comprising a mixture of a) an enteric polymer selected from the group consisting of hydroxypropyl methylcellulose phthalate, hydroxypropyl methylcellulose acetate succinate, cellulose acetate phthalate, polyvinylacetate phthalate, and mixtures thereof; and b) an insoluble film forming polymer selected from the group consisting of cellulose acetate ethylcellulose, and mixtures thereof, wherein the active ingredient is a nonsteroidal anti-inflammatory drug and wherein the weight ratio of enteric polymer to water insoluble film forming polymer in the coating is in the range of about 55:45 to about 80:20.
20 . The method of claim 19 , wherein the surfaces of the particles are substantially free of active ingredient.
21 . The method of claim 19 , wherein the coating is substantially free of plasticizer.
22 . The method of claim 19 , wherein the active ingredient is a nonsteroidal anti-inflammatory drug selected from the group consisting of ibuprofen, ketoprofen, flurbiprofen, naproxen, diclofenac, rofecoxib, celecoxib, aspirin, pharmaceutically acceptable salts and metabolites thereof, and mixtures thereof.
23 . (canceled)
24 . (canceled)
25 . The method of claim 19 , wherein the active ingredient is at least 80% dissolved in 30 minutes in pH 7.2 phosphate buffer when tested according to USP method II at 50 rpm and is at least 70% dissolved in 60 minutes in pH 5.6 acetate buffer when tested according to USP method 11 at 50 rpm.
26 . The particle of claim 1 , wherein the active ingredient is ibuprofen.
27 . The chewable tablet of claim 11 , wherein the active ingredient is ibuprofen.
28 . The method of claim 19 , wherein the active ingredient is ibuprofen.Join the waitlist — get patent alerts
Track US2007196489A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.